Concomitant Treatment of Malignant Brain Tumours With CBD – A Case Series and Review of the Literature

RUDOLF LIKAR; MARKUS KOESTENBERGER; MARTIN STULTSCHNIG; GERHARD NAHLER

doi:10.21873/anticanres.13783

Case ReportClinical Studies

Concomitant Treatment of Malignant Brain Tumours With CBD – A Case Series and Review of the Literature

RUDOLF LIKAR, MARKUS KOESTENBERGER, MARTIN STULTSCHNIG and GERHARD NAHLER

Anticancer Research October 2019, 39 (10) 5797-5801; DOI: https://doi.org/10.21873/anticanres.13783

RUDOLF LIKAR

1Department of Anaesthesiology and Intensive Care, Klinikum Klagenfurt am Wörthersee, Klagenfurt am Wörthersee, Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

MARKUS KOESTENBERGER

1Department of Anaesthesiology and Intensive Care, Klinikum Klagenfurt am Wörthersee, Klagenfurt am Wörthersee, Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

MARTIN STULTSCHNIG

2Neurological Department, Klinikum Klagenfurt am Wörthersee, Klagenfurt am Wörthersee, Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

GERHARD NAHLER

3CIS Clinical Investigation Support GmbH, Vienna, Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: nahler@aon.at

Article
Info & Metrics
PDF

Article Information

vol. 39 no. 10 5797-5801

DOI

https://doi.org/10.21873/anticanres.13783

PubMed

31570484

Published By

International Institute of Anticancer Research

Print ISSN

0250-7005

Online ISSN

1791-7530

History

Received September 5, 2019
Revision received September 17, 2019
Accepted September 18, 2019
Published online September 30, 2019.

Author Information

RUDOLF LIKAR¹,
MARKUS KOESTENBERGER¹,
MARTIN STULTSCHNIG² and
GERHARD NAHLER³ ⇑

¹Department of Anaesthesiology and Intensive Care, Klinikum Klagenfurt am Wörthersee, Klagenfurt am Wörthersee, Austria
²Neurological Department, Klinikum Klagenfurt am Wörthersee, Klagenfurt am Wörthersee, Austria
³CIS Clinical Investigation Support GmbH, Vienna, Austria

Correspondence to: Dr. Gerhard Nahler, CIS Clinical Investigation Support GmbH, Kaiserstrasse 43, 1070 Vienna, Austria. Tel: +43 152340150, Fax: +43 1523401599, e-mail: nahler{at}aon.at

View Full Text

Statistics from Altmetric.com

Cited By...

26 Citations
29 Citations
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

Cannabidiol (CBD) as a Promising Anti-Cancer Drug

Emily S. Seltzer, Andrea K. Watters, Danny MacKenzie, Lauren M. Granat, Dong Zhang

Cancers 2020 12 11
Cannabis sativa: Much more beyond Δ9-tetrahydrocannabinol

Patrícia Alves, Cristina Amaral, Natércia Teixeira, Georgina Correia-da-Silva

Pharmacological Research 2020 157
Can Hemp Help? Low-THC Cannabis and Non-THC Cannabinoids for the Treatment of Cancer

Farjana Afrin, Mengna Chi, Andrew L. Eamens, Ryan J. Duchatel, Alicia M. Douglas, Jennifer Schneider, Craig Gedye, Ameha S. Woldu, Matthew D. Dun

Cancers 2020 12 4
Cannabis, Cannabinoids and Cannabis-Based Medicines in Cancer Care

Donald I. Abrams

Integrative Cancer Therapies 2022 21
Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies

Vamsi Reddy, Dayton Grogan, Meenakshi Ahluwalia, Évila Lopes Salles, Pankaj Ahluwalia, Hesam Khodadadi, Katelyn Alverson, Andy Nguyen, Srikrishnan P. Raju, Pankaj Gaur, Molly Braun, Fernando L. Vale, Vincenzo Costigliola, Krishnan Dhandapani, Babak Baban, Kumar Vaibhav

EPMA Journal 2020 11 2
Cannabinoids in glioblastoma multiforme—hype or hope?

Gary J. Doherty, Bruno H. R. de Paula

British Journal of Cancer 2021 124 8
Cannabis as an Anticancer Agent: A Review of Clinical Data and Assessment of Case Reports

Jordan Guggisberg, Megan Schumacher, Grace Gilmore, Dylan M. Zylla

Cannabis and Cannabinoid Research 2022 7 1
Cannabis sativa subsp. sativa’s pharmacological properties and health effects: A scoping review of current evidence

Xin Yi Lim, Terence Yew Chin Tan, Siti Hajar Muhd Rosli, Muhammad Nor Farhan Sa’at, Syazwani Sirdar Ali, Ami Fazlin Syed Mohamed, Girish Sailor

PLOS ONE 2021 16 1
Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics

Gerhard Nahler

Pharmaceutical Medicine 2022 36 2
Drug–Drug Interactions of Cannabidiol with Standard-of-Care Chemotherapeutics

Tereza Buchtova, David Lukac, Zdenek Skrott, Katarina Chroma, Jiri Bartek, Martin Mistrik

International Journal of Molecular Sciences 2023 24 3
Inhalant Cannabidiol Inhibits Glioblastoma Progression Through Regulation of Tumor Microenvironment

Hesam Khodadadi, Évila Lopes Salles, Ahmet Alptekin, Daniel Mehrabian, Martin Rutkowski, Ali S. Arbab, W. Andrew Yeudall, Jack C. Yu, John C. Morgan, David C. Hess, Kumar Vaibhav, Krishnan M. Dhandapani, Babak Baban

Cannabis and Cannabinoid Research 2023 8 5
miRNA-451 regulates the NF-κB signaling pathway by targeting IKKβ to inhibit glioma cell growth

Yang Nan, Liyun Guo, Yingwei Zhen, Le Wang, Bingcheng Ren, Xingjie Chen, Yalin Lu, Kai Yu, Yue Zhong, Qiang Huang

Cell Cycle 2021 20 19
Cannabidiol inhibits RAD51 and sensitizes glioblastoma to temozolomide in multiple orthotopic tumor models

Liliana Soroceanu, Eric Singer, Pratiksha Dighe, Max Sidorov, Chandani Limbad, Aida Rodriquez-Brotons, Peter Rix, Rinette W L Woo, Lawrence Dickinson, Pierre-Yves Desprez, Sean D McAllister

Neuro-Oncology Advances 2022 4 1
Transient Receptor Potential (TRP) Ion Channels Involved in Malignant Glioma Cell Death and Therapeutic Perspectives

Florence Lefranc

Frontiers in Cell and Developmental Biology 2021 9
Ion Channels in Gliomas—From Molecular Basis to Treatment

Abdallah F. Elias, Bernice C. Lin, Beverly J. Piggott

International Journal of Molecular Sciences 2023 24 3
Cannabis and the Cancer Patient

Ilana M Braun, Donald I Abrams, Stacey E Blansky, Steven A Pergam

JNCI Monographs 2021 2021 58
Dynein Light Chain Protein Tctex1: A Novel Prognostic Marker and Molecular Mediator in Glioblastoma

Claudia Alexandra Dumitru, Eileen Brouwer, Tamina Stelzer, Salvatore Nocerino, Sebastian Rading, Ludwig Wilkens, Ibrahim Erol Sandalcioglu, Meliha Karsak

Cancers 2021 13 11
Cannabinoid Receptor 2 Blockade Prevents Anti-Depressive-like Effect of Cannabidiol Acid Methyl Ester in Female WKY Rats

Danielle Hen-Shoval, Lital Moshe, Talia Indig-Naimer, Raphael Mechoulam, Gal Shoval, Gil Zalsman, Natalya M. Kogan, Aron Weller

International Journal of Molecular Sciences 2023 24 4
Cannabidiol Combination Enhances Photodynamic Therapy Effects on MCF-7 Breast Cancer Cells

Dimakatso Mokoena, Blassan P. George, Heidi Abrahamse

Cells 2024 13 2
Cannabidiol bei Tumorerkrankungen

Rudolf Likar, Markus Köstenberger, Gerhard Nahler

Der Schmerz 2020 34 2
Complementary and Alternative Medicine for the Treatment of Gliomas: Scoping Review of Clinical Studies, Patient Outcomes, and Toxicity Profiles

Dhiraj J. Pangal, Hans Baertsch, Eliza M. Kellman, Tyler Cardinal, Andrew Brunswick, Martin Rutkowski, Ben Strickland, Frances Chow, Frank Attenello, Gabriel Zada

World Neurosurgery 2021 151
Self-reported knowledge of tetrahydrocannabinol and cannabidiol concentration in cannabis products among cancer patients and survivors

Michelle Goulette, Nicolas J. Schlienz, Amy A. Case, Eric Hansen, Cheryl Rivard, Rebecca L. Ashare, Maciej L. Goniewicz, Maansi Bansal-Travers, Andrew Hyland, Danielle M. Smith

Supportive Care in Cancer 2024 32 4
The Influence of Cannabinoids on Multiple Myeloma Cells: A Scoping Review

Karan Varshney, Prerana Ghosh, Akash Patel

Future Pharmacology 2022 2 3
Alles Schmerz: Wer profitiert wovon am meisten?

Schmerz Nachrichten 2022 22 1
Alternative Remedies and Natural Products for Cancer Therapy: An Integrative Approach

Swati Patil, Mandar Mulik

2023
Cannabis medicinal y cáncer: beneficios en dolor oncológico y otros síntomas relacionados

Manuel Herrero Trujillano

Revista de la Sociedad Española del Dolor 2022
Der Nutzen von Cannabis in der Krebstherapie

Franjo Grotenhermen

Deutsche Zeitschrift für Onkologie 2022 54 04
Der Nutzen von Cannabis in der Krebstherapie

Franjo Grotenhermen

Onkologische Welt 2023 14 03
Morpho-anatomical, phytochemical, and molecular diversity of North-Indian Cannabis sativa L. germplasms for CBD-rich genotypes

Dipayan Ghosh, Anitika Kundu, Neha Chaudhary, Sakshi Singh, Karuna Shanker, Birendra Kumar, Narendra Kumar

The Nucleus 2024

PreviousNext

In this issue

Anticancer Research

Vol. 39, Issue 10

October 2019

Table of Contents
Table of Contents (PDF)
Index by author
Back Matter (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Concomitant Treatment of Malignant Brain Tumours With CBD – A Case Series and Review of the Literature

Message Subject (Your Name) has sent you a message from Anticancer Research

Message Body (Your Name) thought you would like to see the Anticancer Research web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 7 + 1 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

Concomitant Treatment of Malignant Brain Tumours With CBD – A Case Series and Review of the Literature

RUDOLF LIKAR, MARKUS KOESTENBERGER, MARTIN STULTSCHNIG, GERHARD NAHLER

Anticancer Research Oct 2019, 39 (10) 5797-5801; DOI: 10.21873/anticanres.13783

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Reprints and Permissions

Concomitant Treatment of Malignant Brain Tumours With CBD – A Case Series and Review of the Literature

RUDOLF LIKAR, MARKUS KOESTENBERGER, MARTIN STULTSCHNIG, GERHARD NAHLER

Anticancer Research Oct 2019, 39 (10) 5797-5801; DOI: 10.21873/anticanres.13783

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

A New Survival Score for Patients Receiving Radiotherapy for Newly Diagnosed Glioblastoma Multiforme

Google Scholar

Keywords

cannabidiol
cannabinoids
chemoradiation
brain tumours
Glioblastoma multiforme

Main menu

User menu

Search

Concomitant Treatment of Malignant Brain Tumours With CBD – A Case Series and Review of the Literature

Article Information

Author Information

Statistics from Altmetric.com

Cited By...

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords